Eisai starts sales for type B botulinus toxin vaccine in Japan

The vaccine is directed towards Torticollis spastica, a disease initiated by Clostridium botulinum toxin B.

Eisai press release, March 26, 2013

Eisai starts sales for type B botulinus toxin vaccine in Japan
Scroll to top